» Articles » PMID: 12776272

The Expanding Spectrum of Renal Diseases Associated with Antiphospholipid Syndrome

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2003 May 31
PMID 12776272
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The association of thrombotic events and/or pregnancy complications with circulating antiphospholipid antibodies defines antiphospholipid syndrome (APS). In previous reports, renal involvement in APS consisted mainly of thrombotic vascular complications involving large vessels or intrarenal small-sized vessels (APS nephropathy). We report 9 cases of glomerulonephritis associated with APS. These cases are characterized by predominant pathological features distinct from vascular APS nephropathy.

Methods: We reviewed consecutive renal biopsies examined in 2 French university hospitals between 1980 and 2002 and identified renal biopsies performed in patients with primary APS.

Results: We identified 29 biopsies performed in patients with APS. Twenty biopsies showed characteristic features of APS nephropathy. In 9 cases, predominant pathological features distinct from vascular APS nephropathy were noted: membranous nephropathy (3 cases), minimal change disease/focal segmental glomerulosclerosis (3 cases), mesangial C3 nephropathy (2 cases), and pauci-immune crescentic glomerulonephritis (1 case). In 7 cases, the presentation of renal symptoms was subacute or chronic. Two patients experienced episodes of acute renal failure. At referral, median creatinine clearance was 50 mL/min (0.83 mL/s) (range, 18 to 117 mL/min [0.30 to 1.95 mL/s]). Proteinuria was noted in all cases (range, 1.5 to 15 g/d), with nephrotic syndrome in 4 cases. Lupus anticoagulant was present in all cases, and anticardiolipin antibodies, in 8 cases. Anti-DNA antibodies repeatedly were negative in all cases. Treatment consisted of antihypertensive therapy (6 cases), anticoagulant drugs (5 cases), steroids (4 cases), and antiplatelet drugs (3 cases). At last follow-up, renal function remained stable in 7 patients. Of 2 patients presenting with acute renal failure, 1 patient recovered normal renal function, whereas the other patient progressed to end-stage renal failure.

Conclusion: The cases reported here represent a new aspect of the expanding spectrum of renal diseases encountered in association with APS.

Citing Articles

Membranous nephropathy in primary antiphospholipid syndrome.

Stammler R, Rapoport C, Van Huyen J, Zuily S, Olivier M, Daugas E Clin Kidney J. 2024; 17(2):sfae017.

PMID: 38370430 PMC: 10872675. DOI: 10.1093/ckj/sfae017.


Antiphospholipid Syndrome Nephropathy Related Disease Diagnosed by Assessing Phosphatidylserine-dependent Antiprothrombin Antibodies.

Suenaga A, Sawa N, Oshima Y, Ikuma D, Oba Y, Yamanouchi M Intern Med. 2022; 62(5):757-761.

PMID: 35908966 PMC: 10037018. DOI: 10.2169/internalmedicine.0302-22.


A Case Report of Intravascular Hemolysis and Heme Pigment-Induced Nephropathy Following AngioJet Thrombectomy for Thrombosed DIPS Shunt.

Tian S, Sinclair N, Shah S Can J Kidney Health Dis. 2021; 7:2054358120979233.

PMID: 33403118 PMC: 7739081. DOI: 10.1177/2054358120979233.


Ischemic Stroke in a Young Patient with Nephrotic Syndrome and Antiphospholipid Syndrome.

Neoh K, Tang A, Looi I, Anita B Case Rep Nephrol. 2020; 2020:8828864.

PMID: 33294240 PMC: 7718048. DOI: 10.1155/2020/8828864.


Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy.

Teisseyre M, Perrochia H, Reboul P, Cariou S, Renaud S, Aglae C BMC Nephrol. 2020; 21(1):196.

PMID: 32448215 PMC: 7247250. DOI: 10.1186/s12882-020-01856-z.